Molecular mechanisms of clarithromycin resistance in Helicobacter pylori

Journal of the Formosan Medical Association

Volumn 97, Issue 7, 1998, Pages 445-452

  Hsieh, Pei Fang ^a   Yang, Jyh Chin ^b   Lin, Jaw Town ^b   Wang, Jin Town ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

23S rRNA gene; 3 oxoadipate CoA transferase; Antibiotic; Clarithromycin; Drug resistance; Helicobacter pylori; Subunit A (yxjD)

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; CLARITHROMYCIN; RNA 23S;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL METABOLISM; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RNA GENE; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CLARITHROMYCIN; COENZYME A-TRANSFERASES; DRUG RESISTANCE, MICROBIAL; HELICOBACTER PYLORI; HUMANS; MOLECULAR SEQUENCE DATA; RNA, RIBOSOMAL, 23S;

EID: 0031817841     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-5.
2. Graham DY, Lew GM, Klein PD, et al: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
3. Sung JJ, Chung SC, Ling TK, et al: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
4. Bayerdorffer E, Neubauer A, Rudolph B, et al: Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
5. Goodwin CS, Blake P, Blincow E: The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986;17:309-14.
6. McNulty CAM, Dent J, Wise R: Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother 1985;28:837-8.
7. Marshall BJ: Treatment of H. pylon. In: Marshall BJ, McCallum RW, Guerrant RL, eds. Helicobacter pylori in Peptic Ulceration and Gastritis. Cambridge: Blackwell Scientific Publications, 1991:160-86.
8. Glupczynski Y: In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment or microbiologist's obsession? Zentralblatl fur Bakteriologie 1993;280:227-38.
9. Rubinstein G, Dunkin K, Howard AJ: The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts. J Antimicrob Chemother 1994;34:409-13.
10. Peterson WL, Graham DY, Marshall B, et al: Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized double-blind trial. Am J Gastroentrol 1993;88:1860-4.
11. van Zwet AA, de Boer Wa, Schneeberger PM, et al: Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands. Eur J Clin Microbiol Infect Dis 1996;15:861-4.
12. DeKoster E, Cozzoli A, Jonas C, et al: Six years resistance of Helicobacter pylori to macrolides and imidazoles. Gut 1996:39(Suppl 2):A1:4.
13. Lópes-Brea M, Domingo D, S'anches I, et al: Metronidazlole and clarithromycin susceptibility amongst H. pylori clinical isolates from different Spanish regions. Gut 1996;39(Suppl 2):A1:37.
14. Vester B, Garrett RA: A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochemistry 1987;69:891-900.
15. Arthur M, Brisson-Noel A, Courvalin P: Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypothesis. J Antimicrob Chemother 1987;20:783-802.
16. Arthur M, Molinas C, Mabilat C, et al: Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes. Antimicrob Agents Chemother 1990; 34:2024-6.
17. Koji OH, Keiko Y: Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. J Antimicrob Chemother 1996;40:1036-8.
18. Arthur M, Autissier D, Courvalin P: Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res 1986;14:4987-99.
19. Noguchi N, Emura A, Matsuyama H, et al: Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli. Antimicrob Agents Chemother 1995;39:2359-63.
20. Rende-Fournier R, Lcclercq R, Galimand M, et al: Identification of the satA gene encoding a streptogramin A acetyltransferase in Escherichia faecium BM4145. J Antimicrob Chemother 1993;37:2119-25.
21. Wondrack L, Massa M, Yang B V, et al: Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 1996;40: 992-8.
22. Schoner B, Geistlich M, Rosteck P, et al: Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins. Gene 1992;115:93-6.
23. Ross JI, Eady EA, Cove JH, et al: Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene 1995;153:93-8.
24. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, et al: Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Letters 1996;142:37-42.
25. Versalovic J, Shortridge D, Kibler K, et al: Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40: 477-80.
26. Hachem CY, Clarridge JE, Reddy R, et al: Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996;24:37-41.
27. von Eggeling F, Spielvogel H: Applications of random PCR. Cell Mol Biol 1995;41:653-70.
28. Chang KC, Ho SW, Yang JC, et al: Isolation of a genetic locus associated with metronidazole resistance in Helicobacter pylori. Biochem Biophil Res Comm 1997;236: 785-8.
29. Wang JT, Tasi FT, Lee CZ, et al: A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996;174:1881-6.
30. Wang Y, Roos KP, Taylor DE: Transformation of Helicobacter pylon by chromosomal metronidazole resistance and b\ a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol 1993;139: 2485-93.
31. Ge Z, Taylor DE: Helicobacter pylori genes hpcopA and hpcopP constitute a cop operon involved in copper export. FEMS Micbiol Letters 1996;145:181-8.
32. Wang JT, Lin JT, Sheu JC, et al: Direct DNA amplification and restriction pattern analysis of Helicobacter pylon in patients with duodenal ulcer and their families. J Infect Dis 1993;168:1544-8.
33. Hiratsuka K: Helicobacter pylori 23S and 5S ribosomal RNA genes, complete sequence. Genbank accession U27270. 1995.
34. Tomb JF, White O, Kerlavage AR: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997;388:539-47.
35. Parales RE, Harwood CS: Characterization of the genes encoding β-ketoadipate: succinyl-coenzzyme A transferase in Pseudomonas putida. J Bacteriol 1992;174:4657-66.
36. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-91.
37. Taylor DE, Ge Z, Purych D, et al: Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. J Antimicrob Chemother 1997;41:2621-8.
38. Steigbigel NH: Macrolides and clindamycin. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases New York: Churchill Livingstone, 1995:334-46.
39. Menninger JR: Functional consequences of binding macrolides to ribosomes. J Mol Biol 1985;16:23-34.